Table 2.
DSS | OS | |||
---|---|---|---|---|
Bivariate (95% CI) | Multivariate (95% CI) | Bivariate (95% CI) | Multivariate (95% CI) | |
Sex (female) | 1.51 (1.35–1.68) | 1.27 (1.14–1.43) | 1.19 (1.09–1.29) | 1.03 (0.95–1.12) |
Age | 1.06 (1.05–1.07) | 1.07 (1.06–1.08) | 1.07 (1.06–1.08) | 1.07 (1.07–1.08) |
Charlson comorbidity | ||||
0 | 1 | 1 | 1 | 1 |
1 | 1.44 (1.24–1.68) | 1.27 (1.09–1.48) | 1.56 (1.40–1.74) | 1.4 (1.25–1.56) |
≥2 | 2.15 (1.91–2.42) | 1.89 (1.68–2.14) | 2.35 (2.15–2.57) | 2.07 (1.89–2.27) |
Stage | ||||
Localized | 1 | 1 | 1 | 1 |
Regional | 2.37 (2.06–2.74) | 2.36 (2.04–2.74) | 1.66 (1.48–1.85) | 1.68 (1.50–1.88) |
Distant | 8.50 (7.24–9.97) | 7.65 (6.48–9.04) | 5.31 (4.63–6.10) | 4.84 (4.20–5.58) |
Unknown | 1.35 (1.17–1.56) | 1.29 (1.12–1.49) | 1.29 (1.17–1.42) | 1.22 (1.10–1.34) |
Cystectomy | ||||
Yes | 1 | 1 | 1 | 1 |
No | 1.06 (0.90–1.24) | 0.91 (0.76–1.08) | 1.38 (1.21–1.58) | 1.11 (0.97–1.29) |
Intravesical therapy | ||||
Yes | 1 | 1 | 1 | 1 |
No | 2.45 (1.96–3.07) | 1.86 (1.48–2.34) | 2.02 (1.74–2.35) | 1.77 (1.52–2.07) |
Intravenous therapy | ||||
Yes | 1 | 1 | 1 | 1 |
No | 0.76 (0.62–0.94) | 0.83 (0.66–1.03) | 0.86 (0.72–1.01) | 0.77 (0.65–0.92) |
Hospital of primary treatment | ||||
Public | 1 | 1 | 1 | 1 |
Private | 0.63 (0.57–0.70) | 0.67 (0.60–0.75) | 0.68 (0.63–0.73) | 0.70 (0.64–0.76) |
Socioeconomic status SEIFA | ||||
Least disadvantaged (Quintile 1) | 1 | 1 | 1 | 1 |
Quintile 2 | 0.85 (0.71–1.02) | 0.88 (0.73–1.07) | 0.94 (0.82–1.08) | 0.97 (0.84–1.11) |
Quintile 3 | 1.07 (0.91–1.26) | 1.17 (0.98–1.39) | 1.09 (0.97–1.23) | 1.17 (1.03–1.33) |
Quintile 4 | 1.01 (0.86–1.19) | 1.15 (0.97–1.37) | 1.03 (0.91–1.16) | 1.12 (0.98–1.27) |
Most disadvantaged (Quintile 5) | 0.98 (0.82–1.16) | 1.03 (0.86–1.25) | 1.11 (0.97–1.26) | 1.16 (1.01–1.34) |
Remoteness of residence (ARIA) | ||||
Major cities | 1 | 1 | 1 | 1 |
Inner regional | 0.99 (0.87–1.12) | 0.98 (0.85–1.12) | 0.99 (0.90–1.09) | 0.95 (0.86–1.06) |
Outer regional/remote | 1.07 (0.86–1.32) | 1.03 (0.82–1.29) | 1.05 (0.90–1.24) | 0.97 (0.82–1.15) |
DSS, disease specific survival; OS, overall survival; ARIA, Accessibility/Remoteness Index of Australia.